Merck KGaA CEO Belen Garijo at Davos

The transcript covers a range of topics including European competitiveness, the impact of regulatory challenges, and the importance of the Capital Markets Union. It speculates on the potential outcomes of the German elections and their impact on investment policies. The discussion shifts to Merck's 25 by 25 policy, highlighting the challenges faced due to the pandemic and other crises. The focus then moves to Merck's drug pipeline, emphasizing the need for external innovation in immunology and oncology. The transcript concludes with a discussion on the importance of the Chinese market and the integration of AI to enhance operational efficiency.

What is the speaker's perspective on the drug pipeline and external innovation?

How does the speaker describe the importance of China as a market?

What role does AI play in the speaker's business strategy?